1-4 of 4
Kevin W. Bruhn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size

Scot D. Liu, Tamar Tomassian, Kevin W. Bruhn, Jeff F. Miller, Françoise Poirier, M. Carrie Miceli
Journal: The Journal of Immunology
J Immunol (2009) 182 (9): 5283–5295.
https://doi.org/10.4049/jimmunol.0803811
Published: 01 May 2009
View article titled, Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size
Open the PDF for Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size in another window
Add to Citation Manager
Journal Articles

The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity

Robert M. Prins, Noah Craft, Kevin W. Bruhn, Haumith Khan-Farooqi, Richard C. Koya, Renata Stripecke, Jeff F. Miller, Linda M. Liau
Journal: The Journal of Immunology
J Immunol (2006) 176 (1): 157–164.
https://doi.org/10.4049/jimmunol.176.1.157
Published: 01 January 2006
View article titled, The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity
Open the PDF for The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity in another window
Add to Citation Manager
Journal Articles

The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant Listeria monocytogenes Vaccine

Noah Craft, Kevin W. Bruhn, Bidong D. Nguyen, Robert Prins, Jia Wei Lin, Linda M. Liau, Jeffery F. Miller
Journal: The Journal of Immunology
J Immunol (2005) 175 (3): 1983–1990.
https://doi.org/10.4049/jimmunol.175.3.1983
Published: 01 August 2005
View article titled, The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant <em>Listeria monocytogenes</em> Vaccine
Open the PDF for The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant <em>Listeria monocytogenes</em> Vaccine in another window
Add to Citation Manager
Journal Articles

Listeria monocytogenes as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy

Holly Starks, Kevin W. Bruhn, Hao Shen, Ronald A. Barry, Thomas W. Dubensky, Dirk Brockstedt, David J. Hinrichs, Darren E. Higgins, Jeffrey F. Miller, Martin Giedlin, H. G. Archie Bouwer
Journal: The Journal of Immunology
J Immunol (2004) 173 (1): 420–427.
https://doi.org/10.4049/jimmunol.173.1.420
Published: 01 July 2004
View article titled, <em>Listeria monocytogenes</em> as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy
Open the PDF for <em>Listeria monocytogenes</em> as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy in another window
Add to Citation Manager